Editor’s Note: Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness

Cancer Discovery · Published 2026-08-03 · DOI 10.1158/2159-8290.cd-26-1218

Authors (25)

Bernhard W. Renz, Takayuki Tanaka, Masaki Sunagawa, Ryota Takahashi, Zhengyu Jiang, Marina Macchini, Zahra Dantes, Giovanni Valenti, Ruth A. White, Moritz A. Middelhoff, Matthias Ilmer, Paul E. Oberstein, Martin K. Angele, Huan Deng, Yoku Hayakawa, C. Benedikt Westphalen, Jens Werner, Helen Remotti, Maximilian Reichert, Yagnesh H. Tailor, Karan Nagar, Richard A. Friedman, Alina C. Iuga, Kenneth P. Olive, Timothy C. Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Renz, B., Tanaka, T., Sunagawa, M., et al. (2026). Editor’s Note: Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-26-1218

Related articles

• Spatial multi-omics implicate the interaction between Tpex and B cells in tertiary lymphoid structures after neoadjuvant therapy · Cancer Discovery · 2026 · Same journal
• PROTEUS May Mean New SOC for Some Prostate Cancers · Cancer Discovery · 2026 · Same journal
• Acquisition of Centromeric Features Supports Telomere Integrity · Cancer Discovery · 2026 · Same journal
• mtDNA Lineage Tracing Reveals Monocyte Fate Bias Prior to Tumor Infiltration · Cancer Discovery · 2026 · Same journal
• Highlighted Research Articles · Cancer Discovery · 2026 · Same journal
• Systematic Targeting of Protein Complexes with Molecular COUPLrs · Cancer Discovery · 2026 · Same journal
• The Promise of Machine Learning–Based Population Screening for Hepatocellular Carcinoma · Cancer Discovery · 2026 · Same journal
• Q&A: Timothy Yap on Clinical Trials and Drug Development · Cancer Discovery · 2026 · Same journal
• In Vivo CAR T-Cell Therapy Spurs 100% ORR in Phase I · Cancer Discovery · 2026 · Same journal
• Genomics of Subsequent Neoplasms in Childhood Cancer Survivors · Cancer Discovery · 2026 · Same journal